This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.Content:
Chapter 1 A Review of Project Management in Life Science Industry Sectors (pages 3–19): Thomas R. Dunson
Chapter 2 The Impact of Organizational Size on Drug Project Management (pages 21–32): Eric Morfin
Chapter 3 Drug Development in Biotechnology and How We Can Do It Better (pages 33–47): Susan Linna
Chapter 4 An Overview of the Organization and Processes of Portfolio, Program, and Project Management (pages 53–57): Pete Harpum
Chapter 5 Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market (pages 59–83): Dr. John Bennett
Chapter 6 Program Management in Drug Development (pages 85–99): Pauline Stewart?Long
Chapter 7 Project Control (pages 101–134): Martin Powell
Chapter 8 Managing Uncertainty in Drug Projects (pages 135–153): Pete Harpum and Thomas R. Dunson
Chapter 9 Managing Drug Safety Risk (pages 155–174): Thomas R. Dunson and Eric Morfin
Chapter 10 Developing Program Strategy (pages 175–196): Pete Harpum
Chapter 11 Developing Products with “Added Value” (pages 197–224): Trevor J. Brown and Stephen Allport
Chapter 12 Integrated Business Processes to Support Cross?Functional Drug Development (pages 227–238): Martin D. Hynes
Chapter 13 Integrated Drug Development: From Cradle to Grave and from Lab to Market (pages 239–258): Stephen Allport and Terry Cooke?Davies
Chapter 14 The Development of P3M Capability in Drug Development Organizations (pages 259–285): John Arrowsmith, Patrick Grogan and Bob Moore
Chapter 15 Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations (pages 287–309): Pete Harpum, Ashley Jamieson and Inge Fisher